DMD Regenerative Therapy
Regenerative medicine for muscular dystrophy.
1st Winner - GENOME English Essay Competition
Problem
Duchenne Muscular Dystrophy involves progressive dystrophin loss. Current treatments are palliative. Regenerative medicine offers potential tissue reconstruction pathways.
Overview
DMD Regenerative Therapy integrates CRISPR-Cas9 gene editing, patient-derived hiPSCs, and nanofiber scaffolds into a personalized regenerative therapy concept for Duchenne Muscular Dystrophy.
Concept
A personalized therapy combining CRISPR editing of patient hiPSCs with nanofiber scaffold delivery to regenerate functional muscle tissue and restore dystrophin expression.
Scope
CRISPR-Cas9 gene editing protocols, human induced pluripotent stem cell generation and editing, nanofiber scaffold biomaterial design, personalized medicine frameworks, regenerative therapy strategies, and pharmaceutical biotechnology.
Contribution
Developed the therapeutic concept, biomaterial strategy, and personalized medicine framework as primary author.
Reflection
This concept demonstrated how converging biotechnologies - gene editing, stem cells, and biomaterials - can address previously untreatable genetic diseases through personalized regenerative approaches.